Protara Therapeutics TARA
NASDAQ TARA
$2.46 -0.04 (-1.60%)
As of: Oct 22, 2026 · 9:36 AM EDT

Protara Therapeutics (TARA) Current Debt (2020)

Updated

Protara Therapeutics (TARA) reported Current Debt of -$557,000 for Q3 2020.

Analysis

Protara Therapeutics (TARA) Current Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,152.37 Bn 1,120.96 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 628.86 Bn 547.39 Bn 17.26 Bn -5.75 Bn
3 AbbVie 500.37 Bn 473.48 Bn 12.70 Bn -
4 Merck 374.01 Bn 328.39 Bn 12.21 Bn -
5 Novartis Ag 300.56 Bn 264.55 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 263.92 Bn 237.60 Bn 12.86 Bn -
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn -
8 Gilead Sciences 192.21 Bn 166.40 Bn 6.22 Bn -
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn 64.00 Mn
10 Protara Therapeutics 150.08 Mn -416.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -371,223.00
Sep 30, 2020 -557,000.00
Jun 30, 2020 -371,000.00
Mar 31, 2020 -370,000.00
API Access

Protara Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=TARA&period=max&api_key=YOUR_API_KEY